Gregory Wilding, PhD

Professor of Oncology
Department of Biostatistics and Bioinformatics
Roswell Park Comprehensive Cancer Center
Chair, Department of Biostatistics
State University of New York at Buffalo
Special Interests: 
Clinical trial design, permutation tests, resampling techniques, goodness-of-fit tests, distributional characterizations, copulas, tests of independence, biostatistics.


Dr. Gregory E. Wilding, Ph.D., is Chair and tenured Professor at the University at Buffalo (UB) Department of Biostatistics. He has been actively involved in many diverse areas of clinical and non-clinical research in academia and industry for approximately 20 years. In addition to Chair, where he oversees all educational, service, and research efforts of the department, Dr. Wilding’s administrative positions also include Director of the Biostatistics, Epidemiology, and Research Design (BERD) Core of the UB Clinical and Translational Science Institute (UB CTSI). The overall objective of the BERD Core is to provide clinical and translational researchers access to a coordinated and collaborative resource for study design and statistical analysis, tailored to the individual needs of investigators. Dr. Wilding holds the additional title of Professor at Roswell Park Comprehensive Cancer Center (Roswell Park). Previous to serving as Chair at UB, Dr. Wilding held the positions of Vice Chair of the Roswell Park Comprehensive Cancer Center Department of Biostatistics and Bioinformatics and Director of the Cancer Center Support Grant (CCSG) Biostatistics Core. During his time at Roswell Park, Dr. Wilding designed well over 300 clinical trials in support of drug, diagnostic device, and medical device development, and reviewed over 1000 clinical trial protocols. He served as the sole statistician on the institute’s data and safety monitoring board, which was responsible for the monitoring of all investigator-initiated trials, and served on the IRB and numerous scientific review committees. Additional appointments held by Dr. Wilding include the UB School of Nursing, Buffalo Center for Social Research, Department of Veterans Affairs, and the UB Jacobs School of Medicine and Biomedical Sciences. As an active consultant to industry, Dr. Wilding has participated in the design and analysis of studies of diagnostic and medical devices and early phase (Phase I and II) drug trials in support of applications to the FDA and non-US regulatory authorities. Additionally, Dr. Wilding has served as a DSMB member for a number of Phase II and III drug trials. Dr. Wilding’s personal methodological research is in the areas of clinical trial design, permutation testing, and tests of independence. He has over 240 papers published in peer-reviewed clinical and statistical journals.


Education and Training: 
PhD - Statistics, University of Rochester
MA - Statistics, University of Rochester
BS - The State University of New York, College at Brockport